March 31, 2016

Novocure and Leading Cancer Center Enter a Preclinical Research Collaboration to Study Tumor Treating Fields

Research Will Be Performed Using Novocure’s inovitro™ System – a Laboratory Research System That Allows Researchers to Apply TTFields to Cancer Cells in Culture March 31, 2016 11:02 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure™ (NASDAQ: NVCR) announced today that Novocure’s inovitro™ laboratory research… Read More
learn more
March 9, 2016

Red Journal Publishes Data Supporting Personalized Treatment Planning to Increase TTFields Efficacy for Patients with Glioblastoma

March 09, 2016 07:00 AM Eastern Standard Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that a computational study analyzing the effect of transducer layout on Tumor Treating Fields, or TTFields, distribution has been published in the International Journal of Radiation Oncology • Biology • Physics, also… Read More
learn more
March 3, 2016

Humana Issues Positive Coverage Decision For Optune

More than 107 million Americans now have coverage of Optune as a treatment for newly diagnosed and/or recurrent glioblastoma March 03, 2016 07:30 AM Eastern Standard Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:NVCR) announced today that Humana now covers Optune for members who have recurrent glioblastoma… Read More
learn more